FORMULATION AND EVALUATION OF ZIDOVUDINE CONTROLLED RELEASE GAS POWERED SYSTEM USING HYDROPHILLIC POLYMER
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2011, Vol 2, Issue 3
Abstract
Zidovudine is the first approved compound for the treatment of AIDS; however the main limitation to therapeutic effectiveness of zidovudine is its dose-dependent toxicity, short biological half-life and poor bioavailability. The present research work an attempt has been made to develop the Zidovudine gas powered drug delivery system for controlled release. The Zidovudine gas powered tablets were prepared by direct compression method by using the different grades of hydrophilic polymer like HPMC. The sodium bicarbonates and citric acid were also used as a gas generating agent. The power blend was subjected for pre-compressional parameters. The prepared gas powered tablets are evaluated to post-compressional analysis of parameter such as hardness, friability, weight variation , thickness, drug content, lag time subsequently buoyancy time and in-vitro dissolution studies and swelling index. All the pre and post-compressional parameter are evaluated the results were within acceptable limits. The results of in-vitro buoyancy time and lag time study, the values of in-vitro buoyancy time ranges from 38 to 960 min where as floating lag time ranges from 3.5 to 60 min. The formulation F4 shows the lag time 3.5 min and buoyancy time 960 min. The results of in-vitro buoyancy time and lag time study revealed that as the concentration of sodium bicarbonate increases there is increase in total buoyancy time and decrease in lag time. It is evident from the in-vitro dissolution data that increase in citric acid concentration increased the release rate but reduced the floating time, probably due to of excess carbon dioxide, disturbing the monolithic tablet. The citric acid level in the formulations greatly influenced the drug release. The formulation, F-4 shows maximum drug release at the end of 12 hrs. Form this study, it is concluded that, the formulation retained for longer periods of time in the stomach and provides controlled release of the drug. Hence it may be increase the therapeutic efficacy of the drug by increasing the bioavailability and patient compliance.
Authors and Affiliations
N. G. Rao, M. Shrishail
Keywords
Related Articles
- EP ID EP129880
- DOI -
- Views 99
- Downloads 0
ORIGINATION AND DEVELOPMENT OF ISOPROTERENOL-INDUCED MYOCARDIAL INFARCTION IN MALE WISTAR RATS
Cardiovascular disease is considered the major cause of morbidity and mortality throughout the world. Catecholamines (epinephrine, norepinephrine and isoproterenol) and their oxidation products cause a direct toxic effec...
ANTIPROLIFERATIVE ACTIVITY OF ETHANOLIC FLOWER EXTRACT FROM NYMPHAEA PUBESCENS WILLD AGAINST HUMAN CERVICAL AND BREAST CARCINOMA IN VITRO
Nymphaea pubescens Willd (Nymphaeaceae) is a fascinating aquatic plant mentioned in siddha system of medicine, in the treatment of bleeding piles, diabetes and as cardiotonic in palpitation of the heart. Nymphaea species...
A VALIDATED SIMULTANEOUS HPLC METHOD FOR DETERMINATION OF ASSAY OF TEMAZEPAM AND FORCED DEGRADATION STUDIES
A new HPLC method was developed for selective and simultaneous determination of of Teamazepam. The developed method is also applicable for the related substances determination in bulk drugs. The chromatographic separatio...
FORMULATION AND EVALUATION OF PRAVASTATIN SODIUM IMMEDIATE RELEASE TABLETS
The aim of present investigation is to develop immediate release formulation of Pravastatin sodium for oral drug delivery by using suitable concentration of superdisintegrants. Croscarmellose sodium (AC-DI-SOL), povidone...
METHOD DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD IN THE DETECTION OF EFAVIRENZ IN BULK DRUG AND TABLET FORMULATION
A simple, highly sensitive, isocratic reversed phase high performance liquid chromatography (RP-HPLC) was developed for the determination of efavirenz in the bulk drug and tablet dosage forms. Elution medium consisting o...